// App-Quantinova.ai

e15600 : Preclinical characterization of GNS561 as a novel first in class autophagy inhibitor to kill hepatocellular carcinoma cancer stem cells.

Researchers

Presenter

  • Firas Bassissi

Principal Investigators

  • Sonia Brun

  • Elena Patricia Gifu

  • Jerome Courcambeck

  • Gregory Nicolas

  • Clarisse Dubray

  • Antoine Beret

  • Nolwenn Amrani

  • Claude Caron de Fromentel

  • Philippe Merle

  • Philippe Halfon

Medical Centers

  • Genoscience Pharma, Marseille, France

  • Centre Leon Berard, Lyon, France

  • Hospices Civils de Lyon, Lyon, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Prominin 1

Drug/Treatment

  • GNS561

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved